Physician profile
David Bercovici
NPI 1568728905
$756.24
in general payments reported to CMS, 2019-2025
12 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $51.49 · 2021: $39.75 · 2023: $95.40 · 2024: $120 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $376.46 | 2019-2025 | Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $157.59 | 2019-2020 | |
| Abbvie INC. | $39.75 | 2021 | |
| Janssen Pharmaceuticals, INC | $37.27 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $31.10 | 2019-2020 | |
| Lilly USA, LLC | $26.89 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $22.36 | 2025 | |
| Amgen INC. | $16.57 | 2019 | |
| Boston Scientific Corporation | $12.87 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.06 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.94 | 2019 | |
| Sanofi Pasteur INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bercovici listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.